#Movember is here, Iet's talk about: testicular cancer (TC). TC affects mostly young men (peak 3rd-4th decade of life).
Awareness and teaching men how to perform self-examination for screening is fundamental.
Make this information known, share it, it may save one man’s life.
Another great presentation from #afufuro team in #EAU22 Congratulations to #FerraguMatthieu for his work on Effect of microvesicles on the growth and environment of RCC 💪💪
Last of the AFUF team but not the least @AHauteclocque presenting today her work: Machine learning approach to predict pT3a upstaging of clinically localized renal cell carcinoma and oncological outcomes after surgery (UroCCR 15 study) 10h30 Purple Area, #EAU22@afufuro
Very interesting and promising study evaluating umbilical cord derived urethral slings in preclinical model
Encouraging results and nice perspective considering the AEs with synthetic mesh
@ugopinar@echartierkastle@Sorbonne_Univ_@HopPitieSalpe
#Teaser Demain ce sera le « D Day » pour Laure BARTHOD, égérie de VILLE HOP’ saison 1. Elle soutiendra sa thèse, mais pas sur le #COVID19… Grand moment d’émotion en perspective. 🙏🏼 pour tout ce que tu as fait durant cette crise sanitaire @ChristineLASSAL @willupano @CecileBebear
Purple urine bag syndrome and why a careful history and basic diagnostic work-up are key to successful management.
Read our latest review here > https://t.co/v3yix5fkPd
Hypogonadal men with Gleason score <8, pT1-2 and pre-operative PSA <10 ng/mL may start testosterone one year after prostate cancer treatment if PSA level is <0.01 ng/mL.
#prostatecancer#eauguidelines
https://t.co/hzdAoWxsG0